Bristol Myers Squibb invests over $400m in sterile drug product facility

Bristol Myers Squibb invests over $400m in sterile drug product facility

Source: 
Biopharma Reporter
snippet: 

Bristol Myers Squibb is investing over $400 million to build a sterile drug product facility at its Dublin campus.